126 related articles for article (PubMed ID: 37983902)
1. Efficient estimation of pharmacokinetic parameters from breast dynamic contrast-enhanced MRI based on a convolutional neural network for predicting molecular subtypes.
Zhang L; Fan M; Li L
Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37983902
[No Abstract] [Full Text] [Related]
2. Convolutional neural network for accelerating the computation of the extended Tofts model in dynamic contrast-enhanced magnetic resonance imaging.
Fang K; Wang Z; Li Z; Wang B; Han G; Cheng Z; Chen Z; Lan C; Zhang Y; Zhao P; Jin X; Liu Y; Bai R
J Magn Reson Imaging; 2021 Jun; 53(6):1898-1910. PubMed ID: 33382513
[TBL] [Abstract][Full Text] [Related]
3. Radiomic Analysis of Pharmacokinetic Heterogeneity Within Tumor Based on the Unsupervised Decomposition of Dynamic Contrast-Enhanced MRI for Predicting Histological Characteristics of Breast Cancer.
Zhang L; Fan M; Wang S; Xu M; Li L
J Magn Reson Imaging; 2022 Jun; 55(6):1636-1647. PubMed ID: 34773446
[TBL] [Abstract][Full Text] [Related]
4. Deconvolution-Based Pharmacokinetic Analysis to Improve the Prediction of Pathological Information of Breast Cancer.
Zhang L; Fan M; Li L
J Imaging Inform Med; 2024 Feb; 37(1):13-24. PubMed ID: 38343210
[TBL] [Abstract][Full Text] [Related]
5. Radiomic features of Pk-DCE MRI parameters based on the extensive Tofts model in application of breast cancer.
Zhou X; Gao F; Duan S; Zhang L; Liu Y; Zhou J; Bai G; Tao W
Phys Eng Sci Med; 2020 Jun; 43(2):517-524. PubMed ID: 32524436
[TBL] [Abstract][Full Text] [Related]
6. Deep learning quantification of vascular pharmacokinetic parameters in mouse brain tumor models.
Arledge CA; Sankepalle DM; Crowe WN; Liu Y; Wang L; Zhao D
Front Biosci (Landmark Ed); 2022 Mar; 27(3):99. PubMed ID: 35345331
[TBL] [Abstract][Full Text] [Related]
7. Estimation of pharmacokinetic parameters from DCE-MRI by extracting long and short time-dependent features using an LSTM network.
Zou J; Balter JM; Cao Y
Med Phys; 2020 Aug; 47(8):3447-3457. PubMed ID: 32379942
[TBL] [Abstract][Full Text] [Related]
8. Generative adversarial network-based synthesis of contrast-enhanced MR images from precontrast images for predicting histological characteristics in breast cancer.
Fan M; Cao X; Lü F; Xie S; Yu Z; Chen Y; Lü Z; Li L
Phys Med Biol; 2024 Apr; 69(9):. PubMed ID: 38537294
[No Abstract] [Full Text] [Related]
9. Fully Automated Convolutional Neural Network Method for Quantification of Breast MRI Fibroglandular Tissue and Background Parenchymal Enhancement.
Ha R; Chang P; Mema E; Mutasa S; Karcich J; Wynn RT; Liu MZ; Jambawalikar S
J Digit Imaging; 2019 Feb; 32(1):141-147. PubMed ID: 30076489
[TBL] [Abstract][Full Text] [Related]
10. Task-based assessment of a convolutional neural network for segmenting breast lesions for radiomic analysis.
Spuhler KD; Ding J; Liu C; Sun J; Serrano-Sosa M; Moriarty M; Huang C
Magn Reson Med; 2019 Aug; 82(2):786-795. PubMed ID: 30957936
[TBL] [Abstract][Full Text] [Related]
11. VTDCE-Net: A time invariant deep neural network for direct estimation of pharmacokinetic parameters from undersampled DCE MRI data.
Rastogi A; Dutta A; Yalavarthy PK
Med Phys; 2023 Mar; 50(3):1560-1572. PubMed ID: 36354289
[TBL] [Abstract][Full Text] [Related]
12. New Explainable Deep CNN Design for Classifying Breast Tumor Response Over Neoadjuvant Chemotherapy.
Adoui ME; Drisis S; Benjelloun M
Curr Med Imaging; 2022; 19(5):526-533. PubMed ID: 36529908
[TBL] [Abstract][Full Text] [Related]
13. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
14. Predicting Breast Cancer Molecular Subtype with MRI Dataset Utilizing Convolutional Neural Network Algorithm.
Ha R; Mutasa S; Karcich J; Gupta N; Pascual Van Sant E; Nemer J; Sun M; Chang P; Liu MZ; Jambawalikar S
J Digit Imaging; 2019 Apr; 32(2):276-282. PubMed ID: 30706213
[TBL] [Abstract][Full Text] [Related]
15. Radiomic versus Convolutional Neural Networks Analysis for Classification of Contrast-enhancing Lesions at Multiparametric Breast MRI.
Truhn D; Schrading S; Haarburger C; Schneider H; Merhof D; Kuhl C
Radiology; 2019 Feb; 290(2):290-297. PubMed ID: 30422086
[TBL] [Abstract][Full Text] [Related]
16. Deep-learning approach with convolutional neural network for classification of maximum intensity projections of dynamic contrast-enhanced breast magnetic resonance imaging.
Fujioka T; Yashima Y; Oyama J; Mori M; Kubota K; Katsuta L; Kimura K; Yamaga E; Oda G; Nakagawa T; Kitazume Y; Tateishi U
Magn Reson Imaging; 2021 Jan; 75():1-8. PubMed ID: 33045323
[TBL] [Abstract][Full Text] [Related]
17. Convolutional Neural Networks for Direct Inference of Pharmacokinetic Parameters: Application to Stroke Dynamic Contrast-Enhanced MRI.
Ulas C; Das D; Thrippleton MJ; Valdés Hernández MDC; Armitage PA; Makin SD; Wardlaw JM; Menze BH
Front Neurol; 2018; 9():1147. PubMed ID: 30671015
[No Abstract] [Full Text] [Related]
18. Noninvasive assessment of breast cancer molecular subtypes on multiparametric MRI using convolutional neural network with transfer learning.
Yin H; Bai L; Jia H; Lin G
Thorac Cancer; 2022 Nov; 13(22):3183-3191. PubMed ID: 36203226
[TBL] [Abstract][Full Text] [Related]
19. Classification of breast mass lesions using model-based analysis of the characteristic kinetic curve derived from fuzzy c-means clustering.
Chang YC; Huang YH; Huang CS; Chang PK; Chen JH; Chang RF
Magn Reson Imaging; 2012 Apr; 30(3):312-22. PubMed ID: 22245697
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
Cheng Z; Wu Z; Shi G; Yi Z; Xie M; Zeng W; Song C; Zheng C; Shen J
Eur Radiol; 2018 Mar; 28(3):982-991. PubMed ID: 28929243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
